SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt clarifies on news item

18 Nov 2019 Evaluate

With reference to news appeared in https://www.moneycontrol.com dated November 18, 2019 quoting Wockhardt: Cipla, Dr Reddys Labs, Carlyle & Asian Investment Fund PAG are in the fray to acquire select business segments of the company, said sources, Wockhardt has submitted a copy of Clarification is enclosed.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1961.20 -2.45 (-0.12%)
29-Jun-2026 13:16 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1877.85
Dr. Reddys Labs. 1384.00
Cipla 1471.65
Zydus Lifesciences 1112.55
Lupin 2385.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: